Pharma Journalist - Page 699 of 831 -

Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ, to the U.S. FDA

Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711

Roche enters into a definitive agreement to acquire Poseida Therapeutics, including cell therapy candidates and related platform technologies

Novartis receives FDA approval for Cosentyx label update

Vaccibody Expands Human Clinical Trial of HPV Vaccine

Astrazeneca’s Brilinta reduces CV events in heart attack survivors

Rexahn Pharma announces collaboration with Zhejiang Haichang Biotechnology

Acesion Pharma receives approval for Phase I Study in Atrial Fibrillation

Certara acquires BaseCase, a Life Sciences Data Visualization Company

Janssen signs deal with theravance Biopharma to develop TD-1473

GSK receives Breakthrough Therapy Designation from FDA for meningitis B vaccine Bexsero

FDA approves Gilead’s Biktarvy for Treatment of HIV-1 Infection

60° Pharmaceuticals (60P) receives priority review designation for Malaria Drug